79 related articles for article (PubMed ID: 26983777)
1. Pancreatic cancer: Advances and challenges.
Halbrook CJ; Lyssiotis CA; Pasca di Magliano M; Maitra A
Cell; 2023 Apr; 186(8):1729-1754. PubMed ID: 37059070
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Han W; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; Shi CT; Ding HZ
PLoS One; 2016; 11(1):e0145803. PubMed ID: 26731428
[TBL] [Abstract][Full Text] [Related]
3. Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma.
Delany AM
Cancer Biol Ther; 2010 Jul; 10(1):65-7. PubMed ID: 20657168
[No Abstract] [Full Text] [Related]
4. Targeting the Cancer-Neuronal Crosstalk in the Pancreatic Cancer Microenvironment.
Capodanno Y; Hirth M
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834436
[TBL] [Abstract][Full Text] [Related]
5. Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high-fat diet.
Xiao G; Wei Y; Xie R; Tsang Y; Gu J; Shen D; Ding M; Yuan J; Xu D; Fei J
FEBS J; 2024 Apr; 291(8):1699-1718. PubMed ID: 38245817
[TBL] [Abstract][Full Text] [Related]
6. Challenges in Recruitment and Retention: Leveraging Health-Related Antecedents and Information Carrier Factors to Improve Patient Participation in Pancreatic Cancer Research-A Review Article.
Coffin TB; Kenner BJ
Pancreas; 2022 Oct; 51(9):1074-1082. PubMed ID: 37078928
[TBL] [Abstract][Full Text] [Related]
7. SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer.
Aghamaliyev U; Su K; Weniger M; Koch D; D'Haese JG; Werner J; Bazhin AV
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9191-9200. PubMed ID: 37188984
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing.
Kozuka M; Battaglin F; Jayachandran P; Wang J; Arai H; Soni S; Zhang W; Hirai M; Matsusaka S; Lenz HJ
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638346
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Stroma in the Management of Pancreatic Cancer.
Edwards P; Kang BW; Chau I
Front Oncol; 2021; 11():691185. PubMed ID: 34336679
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
O'Neill RS; Stoita A
World J Gastroenterol; 2021 Jul; 27(26):4045-4087. PubMed ID: 34326612
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analyses Reveal Prognostic Value of Osteomimicry Across 20 Solid Cancer Types.
Yang C; Pan H; Shen L
Front Mol Biosci; 2020; 7():576269. PubMed ID: 33240930
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-derived SPARC Attenuates M2-mediated Pro-tumour Phenotypes.
Hu J; Ma Y; Ma J; Chen S; Zhang X; Guo S; Huang Z; Yue T; Yang Y; Ning Y; Zhu J; Wang P; Wang X; Chen G; Liu Y
J Cancer; 2020; 11(10):2981-2992. PubMed ID: 32226513
[TBL] [Abstract][Full Text] [Related]
13. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.
Mu W; Wang Z; Zöller M
Front Oncol; 2019; 9():1359. PubMed ID: 31921628
[TBL] [Abstract][Full Text] [Related]
14. Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer.
Ma Y; Zhu J; Chen S; Ma J; Zhang X; Huang S; Hu J; Yue T; Zhang J; Wang P; Wang X; Rong L; Guo H; Chen G; Liu Y
Cancer Cell Int; 2019; 19():137. PubMed ID: 31139014
[TBL] [Abstract][Full Text] [Related]
15. The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection.
Murakawa M; Aoyama T; Miyagi Y; Kobayashi S; Ueno M; Morimoto M; Numata M; Yamamoto N; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
J Cancer; 2019; 10(3):627-633. PubMed ID: 30719160
[No Abstract] [Full Text] [Related]
16. Shattering the castle walls: Anti-stromal therapy for pancreatic cancer.
Kanat O; Ertas H
World J Gastrointest Oncol; 2018 Aug; 10(8):202-210. PubMed ID: 30147846
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel.
Bianconi D; Heller G; Spies D; Herac M; Gleiss A; Liebmann-Reindl S; Unseld M; Kieler M; Scheithauer W; Streubel B; Zielinski CC; Prager GW
Sci Rep; 2017 Jul; 7(1):4851. PubMed ID: 28687745
[TBL] [Abstract][Full Text] [Related]
18. Smoc2 potentiates proliferation of hepatocellular carcinoma cells
Su JR; Kuai JH; Li YQ
World J Gastroenterol; 2016 Dec; 22(45):10053-10063. PubMed ID: 28018113
[TBL] [Abstract][Full Text] [Related]
19. The 'SPARC' of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review).
Rossi MK; Gnanamony M; Gondi CS
Int J Oncol; 2016 May; 48(5):1765-71. PubMed ID: 26983777
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
